Name
Mobista
Alternate Names
None
Abbreviations
None
Category
Ancillary Agent
Subcategory
Flt3 ligand
NSC Number
None
Primary Site
Lymphoma
Histology
None
Remarks
Phase II NHL Recombinant human Flt3 ligand. Immunex.Functions: stimulate blood stem cells, replace cells after chemotherapy damage, increase population of NK's (natural killer cells), NK's target tumor cells, reduced tumors in animal models. Current testing for prostate cancer, melanoma and non-Hodgkin's lymphoma.
Coding
This drug should be coded